Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
BACKGROUND
Sputum analysis is the only non-invasive method to examine airway inflammatory processes in subjects with asthma. The aim of this study was to investigate the relationship between cell counts and fluid phase levels in induced sputum in subjects with mild asthma, and the severity of asthma as assessed by clinical, physiologic and blood measurements.


METHODS
Forty patients with mild asthma, aged 17 to 49 years were studied (good sputum sample only from 31). On the first day, spirometry and methacholine challenges were performed. After 2 to 4 days, venous blood for absolute eosinophil count and eosinophil cationic protein (ECP) measurement was obtained and sputum was induced by inhalation of hypertonic saline. For the next 15 days subjects recorded their peak expiratory flow (PEF), symptom scores, and beta2-agonist requirements twice daily. Differential counts of leukocytes were done on cytospin preparations of homogenized sputum and the supernatant was examined for eosinophil cationic protein (ECP).


RESULTS
Sputum eosinophil counts and not neutrophil, epithelial cells, macrophages, or lymphocytes, were inversely correlated to FEV1/FVC % (r = -.57, P = .0008) and to PC20-methacholine (r = -.40, P = .024). No statistical relationship was obtained between eosinophil counts and either symptom scores, bronchodilator requirements, or daily PEF variability. Sputum ECP values were correlated to FEV1/FVC% (r = -.41, P = .026) but not to PC20 (r = -.32, P = .08) or clinical scores or PEF variation. A trend to significance was appreciated between peripheral blood and sputum eosinophil counts (r = .34, P = .067) and no relationship was found between sputum and serum ECP values (r = .10, P = .38).


CONCLUSIONS
Although sputum markers give some information about disordered lung function and physiologic changes in the airways, they are not the only factors concerned in the clinical expression of mild asthma.
Gutiérrez
V
V
Sección de Alergología, Hospital Dr. Peset, Valencia, Spain.
Prieto
L
L
Torres
V
V
Trenor
R
R
Pérez
C
C
Bertó
J M
JM
Marín
J
J
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000378:metabolism; D000328:Adult; D001249:Asthma / Q000473:pathology* / Q000503:physiopathology*; D001798:Blood Proteins / Q000032:analysis* / Q000502:physiology; D001985:Bronchial Provocation Tests; D002452:Cell Count; D002940:Circadian Rhythm; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000737:chemistry / Q000166:cytology / Q000502:physiology; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000032:analysis*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D012260:Ribonucleases; D012720:Severity of Illness Index; D013183:Sputum / Q000737:chemistry* / Q000166:cytology*
D000318:Adrenergic beta-Agonists; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D018836:Inflammation Mediators; D012260:Ribonucleases